If changes are planned to be made to the manufacturing method due to environmental reasons for example, each national drug authority having granted a marketing authorisation must be proven that the new method does not affect the product’s efficacy or safety, and the marketing authorisations must be updated via a so-called variation procedure to reflect the changed manufacturing method.